{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:03:59Z","timestamp":1749528239080,"version":"3.41.0"},"reference-count":40,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>\n            This article provides guidance on the management of acne vulgaris (AV) and hidradenitis suppurativa (HS) in youth with skin of color (SOC) and youth who are transgender and gender diverse (TGD). Both diseases are associated with delayed diagnosis, treatment disparities, and heightened psychosocial burdens in underrepresented groups. For children with SOC and AV, it is crucial to minimize the risk of postinflammatory hyperpigmentation, with recommendations for starting lower concentrations of retinoids and cautious selection of oral therapies. In children who are TGD, masculinizing hormone therapy for transmasculine individuals may exacerbate acne, necessitating careful treatment planning. In HS, early and aggressive therapy is essential to prevent disease progression and scarring. While biologic agents (eg, adalimumab) demonstrate efficacy, they are underutilized in adolescents. Treatment adherence in both AV and HS can be influenced by systemic barriers to care, highlighting the need for culturally sensitive, multi-disciplinary approaches that address both the dermatologic and psychosocial aspects of care.\n            <jats:bold>\n              [\n              <jats:italic toggle=\"yes\">Pediatr Ann<\/jats:italic>\n              . 2025;54(6):e209\u2013e216.]\n            <\/jats:bold>\n          <\/jats:p>","DOI":"10.3928\/19382359-20250321-04","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:49:52Z","timestamp":1749487792000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Pediatric Acne Vulgaris and Hidradenitis Suppurativa in Minoritized and Underserved Populations"],"prefix":"10.3928","volume":"54","author":[{"given":"Olivia","family":"Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus D.","family":"Boos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-061049"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.04.001"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14693"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.264"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16603"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13896"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14058"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0490B"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2024-006469"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04019.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0049-1"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00643-2"},{"issue":"4","key":"e_1_3_1_16_2","first-page":"434","article-title":"Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color","volume":"12","author":"Woolery-Lloyd HC","year":"2013","unstructured":"Woolery-Lloyd HC, Keri J, Doig S. Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color. J Drugs Dermatol. 2013;12(4):434\u2013437. PMID:23652891","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4818"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15113"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.02.002"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14686"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15114"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.07.043"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.su7304a6"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.10.006"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.09.025"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.067"},{"issue":"3","key":"e_1_3_1_27_2","first-page":"270","article-title":"The Impact of racial differences on treatment strategies in hidradenitis suppurativa: a retrospective review","volume":"21","author":"Robinson I","year":"2022","unstructured":"Robinson I, Lee L, Cotton C. The Impact of racial differences on treatment strategies in hidradenitis suppurativa: a retrospective review. J Drugs Dermatol. 2022;21(3):270\u2013275. PMID:35254766","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16163"},{"issue":"3","key":"e_1_3_1_29_2","first-page":"92","article-title":"Hidradenitis suppurativa in Black and White patients - a clinical study","volume":"27","author":"Byrd AS","year":"2023","unstructured":"Byrd AS, Rosenberg AZ, Shipman WD, . Hidradenitis suppurativa in Black and White patients - a clinical study. Eur Rev Med Pharmacol Sci. 2023;27(3 Suppl):92\u201398. PMID:37129339","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15231"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00796-2"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.5425"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-022-01282-x"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17386"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.059"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.053"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2024.05.004"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.03.008"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19812"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14680"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.009"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:49:57Z","timestamp":1749487797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/19382359-20250321-04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.3928\/19382359-20250321-04"],"URL":"https:\/\/doi.org\/10.3928\/19382359-20250321-04","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}